Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 8, 2019

Primary Completion Date

September 19, 2020

Study Completion Date

September 19, 2020

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

27-hour inpatient intervention

Subjects will be admitted at the research facility at 19:00. Each 27-hour intervention visit includes 3 standardized meals (8:00, 12:00, and 17:00), an evening snack (22:00) and an overnight stay. The glucose level as measured by the real time sensor will be entered manually into the computer every 10 minutes. The infusion rate of either insulin alone or insulin and pramlintide will be changed manually based on the computer generated recommendation. The computer generated recommendations are based on a predictive algorithm.

Trial Locations (1)

H4A 3J1

McGill University Health Centre, Montreal

All Listed Sponsors
collaborator

Diabetes Canada

OTHER

lead

McGill University

OTHER

NCT03800875 - Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting | Biotech Hunter | Biotech Hunter